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We have used DNA microarray analysis of human hepatoma and epithelial carcinoma cells expressing hepatitis C virus (HCV)
subgenomic replicons to test whether HCV replication alters gene expression and influences the alpha interferon (IFN-a) response. We
directly compared the HCV replicon system with a similar system based on a subgenomic replicon of the West Nile virus (WNV) subtype
Kunjin virus. We found that in contrast to WNV replicons, persistent replication of HCV replicons did not significantly alter the transcriptome
of infected cells nor did it inhibit the nature of the IFN-stimulated genes (ISGs). Our results also provided evidence for the existence of a
small number of ISGs that could play a role in the inhibition of HCV replication by IFN-a. Finally, we identified ISGs that are activated by
the cytokine in a cell-type specific fashion.
D 2005 Elsevier Inc. All rights reserved.Keywords: Transcriptome; HCV replicon; InterferonIntroduction
Viral pathogens, such as hepatitis C viruses, interact with
host factors during all steps of their life cycles. Some of
these interactions are required to alter cellular conditions for
replication. For example, HCV, like other members of the
Flaviviridae family of viruses, induces changes in the
organization of endoplasmic reticulum (ER) membranes,
which manifest themselves as membranous web-like struc-
tures (Egger et al., 2002; Westaway et al., 1997). Others
might be required to inhibit cellular antiviral programs that
are normally activated through ‘‘sensors’’ of viral proteins or
nucleic acids (Andrejeva et al., 2004; Yoneyama et al.,
2004). Efforts to uncover host–virus interactions in the
HCV system led to the identification of many interactions
between viral and cellular proteins believed to occur during
HCV replication (Tellinghuisen and Rice, 2002). The list for0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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1 Equal contribution.cellular targets for HCV proteins includes the RNA-
dependent protein kinase (PKR), (Gale et al., 1998), p53
(Alisi et al., 2003; Kao et al., 2004; Kwun et al., 2001; Lan
et al., 2002; Lu et al., 1999; Otsuka et al., 2000), growth
factor receptor-bound protein 2 (Grb2) (He et al., 2002; Tan
et al., 1999), cyclin-dependent kinase 2 (CDK2) (Cho et al.,
2001; Nguyen et al., 2003; Ohkawa et al., 2004) and human
vesicle-associated membrane protein-associated protein A
(hVAP-A) (Evans et al., 2004), among others. Since changes
in the activities of these and other genes are known to
influence gene expression, it is expected that replication of
HCV and related viruses would affect the transcriptomes of
infected cells.
The most striking evidence for the hypothesis that HCV
could play a role in the regulation of gene expression stems
from the observation that a fraction of HCV-infected
patients are resistant to interferon alpha (IFN-a) therapy
(Di Bisceglie and Hoofnagle, 2002). This observation
evoked the possibility that HCV could express a protein
that could reduce or inhibit the activation of certain
interferon-stimulated genes (ISG). However, replication of
HCV in the hepatoma cell line Huh7 is rapidly inhibited by05) 264 – 275
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some ISGs in infected cells (Blight et al., 2000; Frese et al.,
2001; Guo et al., 2001).
Several cell culture studies have addressed the question
about the role of HCV in the regulation of gene expression
and revealed conflicting results (Cheney et al., 2002; Geiss
et al., 2003; Girard et al., 2002, 2004; Scholle et al., 2004;
Zhu et al., 2003a). While some of them relied on results
obtained with cells expressing individual HCV proteins,
others were based on analyses of individual cell lines and
hence, did not permit a careful statistical analysis of the data
sets. Moreover, to date, all experiments with cells express-
ing HCV replicons were made with Huh7-derived cell lines.
Recently, we found that in addition to Huh7 cells, HeLa
cells can also support viral replication (Zhu et al., 2003b).
Notably, we observed that viral replication in HeLa, but not
Huh7 cells, induced changes in the regulation of expression
of the IFN-h gene (Guo et al., 2003). Hence, we tested the
hypothesis predicting that expression of HCV replicons in
Huh7 and HeLa cells induced or repressed specific genes in
both the presence and absence of IFN-a.
Our investigation of four Huh7 and four HeLa-derived
cell lines with and without IFN-a and a proteasome
inhibitor resulted in 30 microarrays, each containing the
expression profiles of 15K genes. For the analysis of the
data, we employed standard statistical procedures for
hypothesis testing, as well as methods for exploration and
visualization of large, multidimensional data sets, such as
Principal Component Analysis (PCA). PCA is a valuable
aid in the exploration of large genomic data sets, allowing
representation of complex data in lower dimensional space,
defined by the Principal Components (PCs) (Misra et al.,
2002). The method has previously been used in the analysis
of microarray data from time-course experiments (Alter et
al., 2000, 2003), normalization of gene expression ratios
obtained from two different microchips (Nielsen et al.,
2002), and for partitioning large-sample microarray-based
gene expression profiles (Peterson, 2003).Table 1
Summary of microarray experiments
Microarray experiment Sample
N2.9, N2.9(df) N2.9
SL1, SL1(df) SL1
KUN, KUN(df) KUNCD20
N2.9cIFN, N2.9cIFN(df) N2.9C + IFN
1Huh7IFN, 1Huh7IFN(df)a Huh7 + IFN
HeLaIFN, HeLaIFN(df) HeLa + IFN
SL1cIFN, SL1cIFN(df)b SL1C + IFN
N2.9IFN, N2.9IFN(df) N2.9 + IFN
1FCA1IFN, 1FCA1IFN(df)a FCA1 + IFN
SL1IFN, SL1IFN(df) SL1 + IFN
KUNIFN, KUNIFN(df) KUNCD20 + IFN
1FCA1exIFN, 1FCA1exIFN(df)a FCA1 + EX + IFN
a These replicate experiments were repeated; the microarrays from the first and
number.
b This microarray was excluded from the analysis because of low quality.Results and discussion
Experimental design
The purpose of this study was to test two hypotheses: the
first predicted that replication of HCV subgenomes altered
the transcriptome of cells; the second proposed that HCV
replication reduced or inhibited the IFN-a response. To test
these hypotheses, we collected data from microarray
experiments with hepatoma (Huh7)- and epithelium
(HeLa)-derived cell lines that replicated HCV subgenomic
replicons (Table 1). In addition to these cell lines, we used
HeLa cells expressing the HCV-related Kunjin virus
subgenomic replicons (termed KUNCD20 cells, see below).
Each microarray was acquired in replicate (dye-flip, df)
resulting in a total of 30 microarrays. The experiments
were subdivided into three groups (Table 1). Group 1
consisted of RNA samples from virus-replicating N2.9,
SL1 and KUNCD20 cells and reference samples from
cured N2.9C and SL1C cells, and normal HeLa cells,
respectively (6 arrays). Cured cells were obtained from
virus-replicating cells by treatment with IFN-a (N2.9C) or
the polymerase inhibitor 2V-C-methyladenosine (2VCMA,
SL1C) (Carroll et al., 2003; Guo et al., 2001). Group 2
included RNA samples from IFN-a-treated normal Huh7
and HeLa cells and from cured Huh7 and HeLa-derived
N2.9 and SL1 cells, respectively. RNA isolated from the
corresponding untreated cells served as a reference for this
group (8 arrays). Group 3 comprised RNA samples from
IFN-a-treated HCV replicating Huh7 (N2.9, FCA1) and
HeLa (SL1) cells and Kunjin replicating HeLa cells
(KUNCD20). The corresponding mock treated cells served
as a reference (8 arrays). In addition, we included arrays
obtained from the Huh7-derived FCA1 cells treated with
IFN-a in the presence and absence of the proteasome
inhibitor epoxomycin (see below). Finally, 3 experiments
including the dye-flips were performed in duplicates as
indicated in Table 1.Reference Cell type HCV isolate
N2.9C Huh7 HCV1b-N
SL1C HeLa HCV1b-Con1
HeLa HeLa Kunjin replicon
N2.9 Huh7 HCV1b-N
Huh7 Huh7 N.A.
HeLa HeLa HCV1b-Con1
SL1C HeLa N.A.
N2.9 Huh7 HCV1b-N
FCA1 Huh7 HCV1b-Con1
SL1 HeLa HCV1b-Con1
KUNCD20 HeLa Kunjin replicon
FCA1 Huh7 HCV1b-Con1
second experiment are denoted in the paper with the corresponding index
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paper are labeled as shown in the first column of Table 1.
The expression ratios, estimated as average over the two
replicates are denoted as the name of the experiment, but in
italics. For example, the average of KUN and KUN(df) will
be denoted as KUN. The complete set of the microarray data
can be obtained from http://www.fccc.edu/research/labs/
seeger/docs.
Data quality control, error estimates and statistical
considerations
As a part of the data-quality assessment procedure the
images of the microarrays were examined. Microarray
SL1cIFN(df) was of low quality and was discarded from
the subsequent analysis. The negative control spots wereFig. 1. (A–C) Correlation plots of the gene expression ratios (on log2 scale) from
cells treated with IFN (1Huh7IFN and 1Huh7IFN(df)); (B) KUNCD20 cells treated
and KUN(df)). The arrows indicate expression ratios of genes, found to be differe
expression ratios (on log2 scale) from replicate (dye-flip) microarray experiments
above which the expression values may be significant for single microarray experim
arrays (D) is significantly lower. (For notation of the microarray experiments, ple
figure legend, the reader is referred to the web version of this article.)investigated on 6 pairs of replicates. Only 77 spots out of
6912 (12  576) had non-zero values, resulting in about 1%
error. Furthermore, only 2 out of the 77 spots had non-zero
intensities in both replicates and thus would be considered
in the subsequent analysis, effectively reducing the error to
0.06% (2 out of 3456).
To assess the variation between the replicate experiments,
we inspected the correlation plots between the estimated
expression intensities, some examples of which are shown in
Fig. 1. The first panel (Fig. 1A) depicts the correlation (r =
0.47) between the replicates of the experiment with IFN-a
treatment of Huh7 cell lines. It is clear that the IFN effects are
related exclusively to up-regulation of a set of genes. These
results were consistent among all other replicates of cell
lines, treated with IFN-a (data not shown) with exception of
KUNCD20 (Fig. 1B). In this case, very few if any expressionpairs of replicates (dye-flip) from microarray experiments from (A) Huh7
with IFN (KUNIFN and KUNIFN(df)); (C) KUNCD20 vs. HeLa cells (KUN
ntially expressed in KUNCD20. (D) Correlation plot of the averaged gene
, repeated with IFN-treated FCA1 cells. The red circle indicates the range,
ents. It can be noted that the error of the averaged values from two replicate
ase refer to Table 1.) (For interpretation of the references to colour in this
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that there were very small effects in the response to IFN-a
treatment. Similarly, very few changes between KUNCD20
and HeLa cells can be observed in Fig. 1C (r = 0.09). This
type of display also aided in determining the magnitude of
ratios that will be considered meaningful for indication of
differential expression. The red circle on the plots indicates
the range (1.58 of log2 scale or 3-fold), above which the
expression values may be significant for single microarray
experiments. Besides these considerations for expression
amplitudes, to further reduce the possibility of false-positives
in our analysis, only genes within 50% variations on log2
scale between the two replicates will be considered. The
rationale of this approach is demonstrated in Fig. 1C, where
the genes satisfying these conditions are marked with arrows.
Finally, averaging the expression ratios from the dye-flip
experiments decreases the variation in the ratio estimates. In
Fig. 1D, the correlation plot between the averages of two
independent experiments with FCA1 cell lines are presented.
In this case, the error in the repeated experiments is lower
and therefore the threshold for significant expression levels
was set to 1 on a log2 scale or 2-fold.
Normal versus HCV replicon expressing cells
To determine whether replication of HCV subgenomes
influenced the levels of gene expression, we performed
DNA microarray analyses with RNA extracted from the
Huh7 and HeLa-derived cell lines N2.9 and SL1, respec-
tively (Group 1, Table 1). As controls for normal expression
levels, we used RNA from the same cells that were cured
from replicons by treatment with IFN-a or 2VCMA, an
inhibitor of the HCV polymerase (Carroll et al., 2003; Guo
et al., 2001). Following the considerations for levels of
expression from the previous section, only average ratios
from the replicates above 3-fold (1.58 on log2 scale) were
considered. Only expression levels with variations between
the two replicates of less than 50% were taken into account.
There were no genes in either of these two cell lines that
satisfied these conditions, indicating that there were either
no changes caused by the replicons or, if there were, their
magnitudes were too small to be detected. In contrast, using
the same approach, twelve differentially expressed genes
could be identified in KUNCD20 cells compared with
normal HeLa cells (Fig. 1C). KUNCD20 cells are HeLa
cells that express a subgenomic replicon derived from
Kunjin virus, a subtype of WNV. Like HCV, WNV is a
positive strand RNA virus belonging to the Flaviviridae
family of viruses (Brinton, 2002). Of the twelve genes, five
were induced and seven repressed (Table S1). However,
since our analysis was limited to only one cell line, we do
not yet know whether this observation represents a general
aspect of WNV infected cells or whether it is a special
feature of the KUNCD20 cell line.
In summary, our results showed that replication of HCV
subgenomic replicons did not induce significant changes inhost cellular gene expression. This conclusion is unex-
pected for several reasons. First, HCV replication induces
dramatic changes in Huh7 and HeLa cells. For example,
Huh7 cells exhibit altered membrane structures, termed
membranous webs, where RNA replication is believed to
occur (Egger et al., 2002). Second, HeLa cells expressing
subgenomic replicons differ from normal HeLa cells in
their response to IFN-a. While normal HeLa cells survive
incubation with the cytokine, replicon expressing cells
undergo apoptosis, indicating that they are in an ‘‘activated
state’’ due to viral replication (Guo et al., 2003). Third, as
stated in Introduction, many laboratories reported on host–
virus interactions between viral proteins and cellular factors.
In particular, NS5A, a non-structural phosphoprotein of
unknown function was found to interact with many cellular
proteins (Macdonald and Harris, 2004). Hence, it is
surprising that despite of these changes in cellular morphol-
ogy and host–virus interactions, gene expression remained
largely unaffected.
Our observations also differed from results of other
gene expression studies revealing that acute and chronic
HCV infections in chimpanzees and human patients could
lead to the induction of ISGs and genes involved in lipid
metabolism (Bigger et al., 2001; Patzwahl et al., 2001;
Su et al., 2002). Although parenchymal cells represent
about 80% of the cells in the liver, it is formally possible
that the observed induction of ISGs occurred primarily in
cells other than hepatocytes. Recent results indicating that
the viral protease could inhibit the activation of the latent
transcription factor IRF3, required for the activation of
IFN-h and a subsets of ISGs, could indicate a role for
non-permissive cells in the regulation of ISG expression
during natural infections (Foy et al., 2003). However, it
is also possible that de novo infected hepatocytes exhibit
an antiviral response before sufficient viral proteins
accumulate to suppress IRF3 activation. Alternatively,
we cannot exclude that in vivo an IFN-independent
pathway controls ISG expression that did not operate in
our cell lines. Finally, it should be noted that many
transformed cell lines, including Huh7 cells, are known
to exhibit defects in pathways involved in the response to
dsRNA (Keskinen et al., 1999) and, as a consequence,
might not express genes normally induced by replication
of RNA viruses.
Does HCV replication alter the cellular response to IFN-a?
To test the hypothesis predicting that HCV replication
could inhibit the IFN-a response in infected cells, we
incubated normal and HCV replicating Huh7 and HeLa-
derived cell lines with 100 IU of IFN-a for 6 h and then
isolated total RNA for DNA microarray analysis (see
Materials and methods). As controls, we also included two
sample sets that were expected to exhibit differences in the
expression of IFN-induced genes. The first set was obtained
from the Huh7-derived cell line FCA1 incubated with IFN-
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of chymotrypsin-like proteases and hence, inhibits the
proteasome (Meng et al., 1999). For unknown reasons, the
drug partially inhibits the IFN response and, as a conse-
quence, prevents the inhibition of HCV replication normally
observed in the presence of the cytokine (Guo et al., 2003).
The second set was obtained from KUNCD20 cells, which
have lost the ability to respond to IFN-a due to replication
of the Kunjin replicon (Guo et al., 2005).
Principal component analysis (PCA) of the ratios of all
genes in the data set revealed a modest separation between
Huh7 (Fig. 2, red spots) and HeLa-derived cell lines (blue
spots) that was, as expected, most pronounced with the
epoxomycin treated FCA1 cells (FCA1ex ) and the
KUNCD20 cells. The proximity between SL1 and N2.9
and their cured derivatives, respectively, on the PCA plot
suggested a close similarity of their gene-expression patterns
in response to IFN-a. Consistent with this observation, aFig. 2. Representation of gene-expression patterns of IFN-a-treated cell
lines in a plane defined by the first two principal components. Each point
represents an average from two-replicate (dye-flip) 15K arrays (with
exemption of SL1C). HeLa cell lines (KUNCD20 (Kun), HeLa, SL1 and
SL1c) are represented by blue points; Huh7 cell lines (N2.9, N2.9c, Huh7,
FCA1 and FCA1ex) are represented by red spots (the experiments with
Huh7, FCA1 and FCA1ex cell lines were repeated). This representation
suggests a separation between the blue and red spots, indicating differential
gene-expression profiles between HeLa and Huh7 cell lines in response to
IFN-a treatment. The proximity between the cured and infected cell lines
(SL1 and N2.9) confirms the close similarity of their gene-expression
patterns. The PCA representation also places Kun and FCA1ex as most
distant points from the distribution of HeLa and Huh7 samples.paired t test with a hypothesized zero-difference in the means
between the estimated ratios of all genes in the averaged
arrays N2.9 and N2.9c revealed no significant difference
(P = 0.60). Similarly, we did not find a significant
difference between SL1IFN and SL1cIFN (P = 0.92). To
increase the sensitivity of the test, we applied it to the
expression ratios of genes that were up-regulated more than
2-fold (for N2.9) and 3-fold (for SL1) in at least one of the
compared pairs. There were 101 and 158 such genes in cured
and infected N2.9 and SL1 cell lines, respectively (lists of
these genes can be obtained from http://www.fccc.edu/
research/labs/seeger/docs). Again, no significant difference
was detected (P = 0.83 and 0.76, respectively). In contrast,
an analogous comparison of normal HeLa cells with
KUNCD20 cells, or of FCA1ex and FCA1 cells revealed a
significant difference (P < 0.015 in both cases). Hence, our
analysis did not provide any support for the hypothesis that
HCV replication could alter the IFN-a response in Huh7 or
HeLa cells. It should be noted that if such changes exist,
their magnitude are below the sensitivity of the current pair
comparisons in this microarray experiment.
A common practice in analysis of such pair experiments
is to determine genes, which are 2-fold up- or down-
regulated in one cell line versus another. Indeed, there were
14 and 45 genes, which were up-regulated in the N2.9 and
SL1, relative to the cured (N2.9c and SL1c) and 9 and 26
genes were correspondingly down-regulated. Hence, our
results showed that it is possible to identify differentially
expressed genes with a single cell line essentially as
reported by other laboratories (Zhu et al., 2003a). However,
in the absence of solid statistical evidence about the
significance of these differences, it is more likely that such
changes are due to natural variations between the compared
pairs and might reflect cell line specific properties and
hence, might not be a general consequence of HCV
replication. To directly address this issue, we tested the
differences between the individual microarray data from
virus infected and non-infected cell lines. In the case of
Huh7 cells, we considered 1Huh7IFN, 1Huh7IFN(df),
2Huh7IFN, 2Huh7IFN(df), N2.9cIFN, N2.9cIFN(df) as a part
of the virus-free group and N2.9IFN, N2.9IFN(df),
1FCA1IFN,1FCA1IFN(df), 2FCA1IFN, 2FCA1IFN(df) as part
of the virus infected group. Two-sided t test revealed that
the expression ratios of only 272 genes (out of 14912) had
significant differences (P < 0.05), 473 fewer than expected
by chance (0.05  14912 = 745). Moreover, the expression
of only ten of those genes differed more than 2-fold between
virus replicating and virus-free cells and only two of these
genes were overlapping with the up-regulated genes,
determined by the comparison between N2.9 and N2.9c
(NM_002462_1-myxovirus (influenza) resistance 1, homo-
log of murine (interferon-inducible protein p78); mx1 and
NM_016323_1-cyclin-e binding protein 1; loc51191). In the
case of HeLa cells, we conducted similar tests, comparing
the virus-free cell lines HeLaIFN, HeLaIFN(df) and SL1cIFN
vs. the infected cell line SL1IFN, SL1IFN(df). Significant
Table 2
Summary of statistical analysis of HeLa and Huh7 microarray data
Cell lines
HeLa Huh7
Representative microarray
experiments from derivative
cell lines
HeLa,
SL1,
SL1c
N2.9, N2.9c, 1HUH7,
2HUH7, 1FCA1,
2FCA1
Genes with non-zero ratios in all
microarray experiments in
the group (n)
9, 939 11,652
Average standard deviationa,b 0.286 0.176
Differentially expressed genes in
IFN-treated cells vs.
controls (P < 0.05) (n)
527 2, 269
Induced genesc (n) 62 96
Genes, induced more than
10-fold (Class 1) (n, %e)
8 (13%) 12 (12%)
Genes, induced 3- to
10-fold (Class 2) (n, %e)
32 (52%) 47 (49%)
Genes, induced 2- to 3-fold
(Class 3) (n, %e)
22 (35%) 37 (39%)
a Estimated as an average of standard deviations across ratios of the
expressed genes.
b Values are presented on log2 scale.
c Genes with expression ratio larger than 1.00 on log2 scale (2-fold
induction).
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and virus-infected cells were found for 535 genes, again
fewer than expected by chance. Sixteen genes were more
than 2-fold differentially expressed between the two groups
and only one of them (NM_016816_1-2V,5V-oligoadenylate
synthetase 1, isoform e18; oas1) was overlapping with the
up-regulated genes identified by the comparison between
SL1cIFN and SL1IFN. Again, this analysis confirmed the
conclusion from the previous data revealing a lack of
reliable evidence for a differential response to IFN-a among
normal and replicon-expressing cell lines. Consistent with
this conclusion, replicon expressing cell lines were pro-
tected against infection with vesicular stomatitis virus in the
presence of IFN-a, indicating that the cytokine induced an
antiviral state as observed with normal control cells (Guo et
al., 2005).
Identification of common and differentially expressed ISGs
in HeLa and Huh7 cells
A major question concerns the mechanism by which
IFN-induced genes inhibit viral replication. A major
obstacle in resolving this problem lies in the large number
of genes that are activated by the cytokine. IFN-a inhibits
HCV replication in Huh7 and HeLa cells with comparable
efficiencies (Zhu et al., 2003b). Since the two cell lines
were derived from different tissues (hepatoma and cervical
carcinoma), we considered the possibility that this tissue
difference was also, at least in part, reflected in the nature
of the genes that were activated by IFN-a. Moreover, a
previous report by Schlaak et al. (2002) provided evidence
for the cell-type specific induction of genes in response to
IFN-a treatment. Their study compared the expression of
150 known ISGs in peripheral blood monocytes and
established cell lines including Huh7, but not HeLa cells.
To test our hypothesis, we compared the nature of the
IFN-induced genes in the two cell types, represented by
HeLa, SL1 and SL1c (HeLa) and N2.9, N2.9c, 1HUH7,
2HUH7, 1FCA1, 2FCA1 (Huh7). The goal of the initial
statistical analysis was identification of genes that are
differentially expressed in the IFN-treated cells as compared
to controls. For each gene, the null hypothesis, that the mean
ratios of the data are 1 (on log2 scale, 0), was tested using a
two-sided, one-sample t test. The t statistic was calculated
for genes with non-zero values in all arrays for each
experiment in the group. The summary of this analysis is
presented in Table 2. The number of differentially expressed
genes in the IFN-treated cells is larger than anticipated
based on the false-positive rate of the statistical test (5%).
Also, it should be noted that significant t values could be
reached not only when the magnitude of the ratios is large,
but for relatively small numbers consistently expressed
within the series. Thus, our analysis further focused on
differentially expressed genes with expression ratios larger
than 1 on log2 scale (2-fold induction). These genes were
assigned into 3 classes based on their levels of induction:Genes that were induced more than 10-fold were considered
Class 1, those induced 4- to 10-fold Class 2 and those 2- to
3-fold Class 3. According to this classification, Class 2
contained the largest number of genes for both HeLa and
Huh cell lines (Table 2). There were 51 genes, simulta-
neously up-regulated in the two cell lines (Table 3).
The number of identified ISGs in our analysis compares
favorably with the reported ISGs in a study by Der et al.
(1998). In this report, the mRNA profiles from IFN-a, -h or
-g treatments of the human fibrosarcoma cell line, HT1080,
were determined by using Affymetrix arrays with probe sets
corresponding to more than 6,800 human genes. A total of
122 ISGs were identified, out of which 65 genes were up-
regulated more than 2-fold after treatment with IFN- a.
Fifteen of these genes are identical with genes reported in
Table 3 (marked with three asterisks). The fold-up-regu-
lation of these 15 genes in the two studies is in good
agreement (r = 0.53 and 0.44 for HeLa and Huh,
respectively), considering the vast differences in the
experimental conditions (different cell lines, microarray
platforms) and in the processing of the raw data. In fact,
when the same cell lines were used as in the study by Zhu et
al. (2003a), the correlation between the expression of IFN-
induced genes was improved (r = 0.70).
To identify genes whose activation was cell line
specific, the two-sample t test was applied to the ratios
between IFN-treated and control HeLa and Huh7 cells. A
total of 968 genes (P < 0.05) were differentially expressed
between the two sets containing HeLa (HeLa, SL1 and
SL1c) and Huh7 (N2.9, N2.9c, 1HUH7, 2HUH7, 1FCA1,
2FCA1) derived cell lines. Following the established
Table 3
Commonly IFN-induced genes in HeLa and Huh7 cellsa
a Class of genes as defined in Table 2 is indicated with the shades of gray. Darkest, Class 1; medium, Class 2; and white, Class 3.
*Induction levels in Huh7 are significantly different in comparison to HeLa ( P < 0.05) (see Table 4).
**Induction levels in HeLa are significantly different in comparison to Huh7 ( P < 0.05) (see Table 4).
***ISGs identified by Der et al. (1998).
J. Hayashi et al. / Virology 335 (2005) 264–275270criteria for differences, larger than 2-fold, a total of 11 and
14 genes were up-regulated (or induced) in HeLa and Huh7
cells, respectively (Table 4). Finally, our analysis did not
reveal any evidence for the repression of gene expression
in IFN-treated cells.Identification of ISGs that could play a role in the inhibition
of HCV replication
Under the assumption that the same genes in HeLa
and Huh7 cells are responsible for the inhibition of HCV
J. Hayashi et al. / Virology 335 (2005) 264–275 271replication, the number of candidate genes (51) was still
large. To further reduce the number, we took advantage
of a previous observation indicating that the incubation of
cells with epoxomycin, an inhibitor of the chymotrypsin-
like activity of proteasomes, inhibited the activation of a
few selected ISGs (Li and Hassel, 2001). Moreover, we
found that epoxomycin abolished the antiviral activity of
IFN-a against HCV replicons (Guo et al., 2003). Based
on these results, we speculated that epoxomycin could
prevent the induction of a larger subset of ISGs and
hence, could be useful for the subsequent identification of
the genes required for the suppression of HCV repli-
cation. To test this hypothesis, we compared the gene
expression profiles of 96 IFN-induced genes in FCA1
cells in the presence and absence of epoxomycin. The
majority of these genes (62) were up-regulated more than
2-fold in the presence of IFN-a and the drug. Notably,
the expression levels of about one third of the genes (32
genes) were very similar (within 20%) in both series.
However, a closer inspection of the results revealed that
epoxomycin suppressed the activation of at least five
genes (Table 5). Among them is the gene encoding 2V–5V
oligoadenylate synthetase 2 (oas2), which belongs to a
family of genes known to play a major role in the
induction of an antiviral response. Notably, one of the
OAS genes (oas1b) was recently identified as the gene
responsible for the resistance of certain strains of mice to
infections with the HCV-related West Nile virus (Perely-
gin et al., 2002). Considering the relatively small number
of candidate genes, it might now be possible to determine
the role of each individual gene for its activity against HCV
replicons with siRNA technology.
Summary and conclusions
The comprehensive DNA microarray analysis of HCV
replicating and normal cells revealed that expression of
subgenomic HCV replicons in cells of different origin had
no significant effect on the transcriptomes. Moreover, the
results showed that replication of subgenomes did not
interfere with the activation of IFN-induced genes.
Similarly, Scholle et al. (2004) concluded from their
DNA microarray analysis, which comprised Huh7-derived
cell lines expressing full-length HCV replicons and their
cured counterparts, that HCV replication did not induce
significant changes on cellular transcription. Also, Geiss et
al. (2003) and Zhu et al. (2003a) concluded from their
studies that replication of HCV subgenomes did not
significantly alter the induction of ISGs in Huh7 cells.
In agreement with the latter report, we also found that the
amplitude of some of the ISGs is larger in HCV
replicating cells compared with normal cells (results not
shown). The combined results from those and our studies
stand in apparent conflict with several other reports
claiming that expression of HCV proteins, in particular
the non-structural protein NS5A, could activate the tran-scription of several cellular genes (Ghosh et al., 2000,
2003; Girard et al., 2002, 2004; Gong et al., 2001; Polyak
et al., 2001; Tan et al., 1999) and citations in (Scholle et
al., 2004). A major difference between those reports and
ours was that the former were carried out with cells that
expressed an individual viral protein under conditions that
did not support viral replication.
Although the exact number of IFN-induced genes was
difficult to determine because it depended on the cell lines
and the microarray platform used for the experiments, there
was a good correlation between this and previously
published studies. The first report by Der et al. (1998)
identified 65 genes that were more than 2-fold induced in
the human fibrosarcoma cell line HT1080 by IFN-a and our
study identified 51 genes for both types of cells with a
confidence level (P > 0.05). Moreover, our study revealed
25 ISGs with differential expression, depending on the cell
type: 11 genes up-regulated in HeLa and 14 genes in Huh7
cells. Similar observations were made by Schlaak et al.
(2002) with lymphocytes and established transformed cell
lines. Such changes could be explained by differences in the
chromatin structure that influence the binding of IFN-
induced transcription complexes to the promoters of ISGs
and (or) by differences in the activation of additional signal
transduction pathways that could influence the activation of
certain ISGs. Finally, with the help of epoxomycin, we
demonstrated that the induction of a small subset of ISGs
depended on functional proteasomes. The mechanism for
this regulation is not yet understood. Nevertheless, since
IFN-a could not inhibit HCV replication in the presence of
epoxomycin (Guo et al., 2003), our study identified a small
number of candidate genes that might be responsible for the
antiviral activity of this cytokine.Materials and methods
Cell lines
The cell lines used for this study were previously
described (Guo et al., 2001, 2003; Zhu et al., 2003b).
Briefly, cell lines FCA1 and N2.9 were derived from Huh7
cells transfected with HCV subgenomic replicons I377/NS3-
3V(Con1) and HCV-N, respectively. The cell lines SL1 and
KUNCD20 were derived from HeLa cells transfected with
HCV and Kunjin-based subgenomic replicons. FCA1C,
N2.9C and SL1C are cell lines that were cured from HCV
replicons after incubation with IFN-a or the polymerase
inhibitor 2VCMA (Carroll et al., 2003). The cells were
grown in Dulbecco’s modified Eagle’s medium (DMEM)
(Gibco-BRL) supplemented with 10% fetal bovine serum,
l-glutamine, nonessential amino acids, penicillin and
streptomycin. To activate the IFN response, cells were
cultured in the presence of 100 IU/ml recombinant IFN-a
2b (Intron A, Schering-Plough) for 6 h before RNA was
extracted.
Table 4
Differentially IFN-induced genes in HeLa and Huh7 cells
Gene ID Fold
change in
HeLa
cells
Fold
change in
Huh7
cells
Diff.
upregulated in
HeLa vs. Huh7
(fold)
NM_005531_1—interferon,
gamma-inducible protein16;
ifi16
9.10 0.95 9.60
XM_038988_1—similar
to unknown (protein for
image:3155889)
(h. sapiens); loc126883
7.46 1.15 6.49
NM_006417_1—interferon-
induced, hepatitis
c-associated microtubular
aggregat; mtap44
11.38 2.04 5.59
NM_002463_1—myxovirus
(influenza) resistance 2,
homolog of murine; mx2
6.40 1.26 5.07
NM_001572_1—interferon
regulatory factor 7
isoform a; irf7
3.18 1.08 2.95
XM_012718_1—secreted
and transmembrane 1
precusor; sectm1
2.26 0.92 2.45
NM_016489_1—uridine
5Vmonophosphate
hydrolase 1; umph1
5.23 2.18 2.40
NM_004285_1—hexose-6-
phosphate dehydrogenase
precursor; h6pd
2.49 1.13 2.20
NM_014314_1—rna helicase;
rig-i
12.30 5.62 2.19
NM_017458_1—major vault
protein; mvp
1.96 0.92 2.13
NM_004184_1—
tryptophanyl-trna
synthetase; wars
2.39 1.15 2.09
Huh7 vs. HeLa
XM_054401_1—putative
breast epithelial stromal
interaction protein; epsti1
0.95 11.03 11.60
XM_039079_1—hypothetical
protein xp_039079;
loc91543
1.04 7.10 6.85
NM_002800_1—proteasome
(prosome, macropain)
subunit, beta type, 9
(large multifunctional
protease 2); psmb9
3.51 14.81 4.22
NM_001565_1—interferon
gamma-induced precursor;
scyb10
2.97 10.20 3.43
NM_022168_1—melanoma
differentiation associated
protein-5; mda5
5.36 16.19 3.02
AF161416_1—hspc298 0.70 1.97 2.79
NM_005567_1—galectin
3 binding protein;
lgals3bp
2.46 5.73 2.33
NM_006398_1—diubiquitin;
ubd
1.09 2.51 2.30
Gene ID Fold
change in
HeLa
cells
Fold
change in
Huh7
cells
Diff.
upregulated in
Huh7 vs. HeLa
(fold)
NM_004556_1—nuclear
factor of kappa light
polypeptide gene enhancer
in b-cells inhibitor, epsilon;
nfkbie
0.75 1.71 2.29
NM_000584_1—interleukin 8;
il8
1.06 2.42 2.29
NM_000585_1—interleukin 15;
il15
1.33 3.01 2.26
NM_016347_1—putative
n-acetyltransferase camello 2;
cml2
0.97 2.04 2.11
NM_004591_1—small inducible
cytokine subfamily a (cys-cys),
member 20; scya20
0.97 2.02 2.08
NM_018559_1—
lipopolysaccharide
specific response-7 protein;
lsr7
1.19 2.40 2.03
Table 4 (continued)
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Total cellular RNAs were extracted with TRIzol reagent
(Invitrogen) and further purified with a RNAeasy kit
(Qiagen). A total of 25 Ag of each RNA sample was used
as a template to make cDNA by reverse transcription with
oligo(dT)12–18 primer and dNTP mixed with amino allyl-
dUTP using a cDNA indirect labeling kit essentially as
described (Frolov et al., 1998). The cDNA was then
purified and labeled with N-hydoxysuccinimide (NHS)-
ester containing Cy3 or Cy5 dye in coupling reactions
(Amersham Biosciences). The labeled probes were purified
using the QIAquick PCR purification kit (Qiagen) by
following the manufacturer’s direction and hybridized to a
microarray containing oligonucleotides specific for 15,552
human genes (MWG Biotech, High point, NC) in 38 Al of
hybridization buffer (5 SSC, 0.1% SDS and 50%
formamide) at 42 -C for 16 h. DNA microarrays were
prepared at the Fox Chase Cancer Center. Arrays were
spotted onto polylysine-coated glass slides using a
GeneMachine Omnigrid arrayer (GeneMachine, San Car-
los, CA). The slides were exposed to UV light (90 mJ) in
a Stratalinker(Stratagene, La Jolla), and processed as
described in the Mguide, Version 2.0 (http://www.smgm.
Stanford.edu/pbrown/mguide/index.html).
The slides were scanned with a GMS 428 Scanner
(Affymetrix, Santa Clara, CA) at laser intensity and photo-
multiplier tube voltage settings, allowing for full dynamic
range for each slide in the respective channel. Image
segmentation and spot quantification were performed with
the ImaGene software v. 5.6 (BioDiscovery, Marina del Rey,
CA).
Table 5
Differentially expressed genes in IFN-treated Huh7 and epoxomycin treated
FCA1 cells
Gene ID Huh7a EPOX Fold
difference
NM_001565_1—interferon
gamma-induced precursor; scyb10
10.20 0.93 11.0
NM_016817_1—2V–5Voligoadenylate
synthetase 2, isoform p71; oas2
10.60 1.72 6.2
NM_002800_1—proteasome
(prosome, macropain) subunit,
beta type, 9 (large multifunctional
protease 2); psmb9
14.81 7.15 2.1
NM_017654_1—hypothetical
protein flj20073; flj20073
8.57 3.54 2.4
NM_002462_1—myxovirus
(influenza) resistance 1,
homolog of murine (interferon-
inducible protein p78); mx1
10.46 5.75 1.8
NM_005567_1—galectin 3 binding
protein; lgals3bp
5.73 1.41 4.1
XM_054401_1—putative breast
epithelial stromal interaction
protein; epsti1
11.03 7.25 1.5
XM_039079_1—hypothetical
protein xp_039079; loc91543
7.10 3.46 2.1
D28137_1-bst-2 4.85 1.43 3.4
NM_003661_1—apolipoprotein l;
apol
4.35 1.10 4.0
NM_002534_1—2V,5V-oligoadenylate
synthetase 1, isoform e16; oas1
4.69 1.62 2.9
NM_004688_1—n-myc and stat
interactor; nmi
5.72 3.14 1.8
NM_004585_1—retinoic acid
receptor responder
(tazarotene induced) 3; rarres3
3.95 1.40 2.8
AF159441_1—phospholipid
scramblase 2
8.00 5.46 1.5
U88964_1-hem45 4.36 2.09 2.1
NM_006820_1—hypothetical
protein, expressed in
osteoblast; gs3686
4.12 1.87 2.2
NM_005082_1—zinc finger
protein 147; znf147
7.34 5.19 2.15
a Huh7 indicates the average calculated from all Huh7-derived cell lines
described in Table 1.
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The gene expression ratios were calculated using Gene-
Sight v. 4.1 (BioDiscovery, Marina del Rey, CA). The mean
pixel intensities of the spot and the area surrounding the
spot, termed local background, were used throughout the
study. Spots with intensities below the sum of the mean plus
2 standard deviations of the local background were flagged
as Fempty_. Genes, corresponding to spots with intensities
below the threshold in both channels were considered non-
expressed and excluded from further analysis. The values
for the local background were subtracted from the signal
intensities of each spot. Spots, with intensity less than 20
intensity units were Ffloored_ to 20. The data was log2
transformed and normalized for the different incorporation
rates of Cy3 and Cy5 using Lowess fit (Yang et al., 2002).The log2 of the ratio of the intensities of Cy5-channel over
Cy3-channel was calculated by subtracting the correspond-
ing normalized values of the spot intensities. The reciprocal
value of the ratios was used for the dye-flip experiments.
The log2 ratio of the non-expressed genes was set to 0.
Quality control procedures
The quality of the scanned microarray images was
examined visually. As part of the quality-control procedures,
blank spots (576 spots out of 15K) served as negative
controls.
Statistical analysis
The initial statistical analysis addressed the question of
whether there are genes that are differentially expressed in
normal and IFN-a treated cells. For each gene, the null
hypothesis, that the mean ratio of the data is 1 (on log2 scale,
0), was tested using a two-sided, one-sample t test. The t
statistic was calculated for genes with non-zero values in all
replicate arrays.
For the purpose of exploring the overall differences
between samples, we applied PCA to a data matrix
containing the averaged between the replicates (dye-flip)
gene expression ratios. Thus, each cell line is represented as
a point in a coordinate system, defined by the PCs. The
distances between the samples reflect the differences or
similarities between their gene-expression profiles.Acknowledgments
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